Abstract

Hypothermic oxygenated perfusion (HOPE) is an emerging technique for donor heart preservation that is currently being studied in multiple clinical trials with promising results. When compared to HOPE for other organs, cardiac protocols involve red blood cell (RBC) supplementation, despite absence of comparative evidence for its benefits. In this perspective paper, we discuss the pros and cons of the addition of RBCs during cardiac HOPE. Although the current clinical results with RBC supplementation during HOPE seem promising, potential downsides of RBC supplementation cannot be ruled out. The impact of supplemented RBCs during cardiac HOPE requires further investigation to improve HOPE protocols, to optimize heart preservation using this promising technology.

Original languageEnglish
Pages (from-to)285-288
Number of pages4
JournalThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Volume44
Issue number2
Early online date4 Oct 2024
DOIs
Publication statusPublished - Feb 2025

Keywords

  • cardiac HOPE
  • donor heart preservation
  • ex-situ heart perfusion
  • heart transplantation
  • red blood cells

Fingerprint

Dive into the research topics of 'A Perspective on the Added Value of Red Blood Cells during Cardiac Hypothermic Oxygenated Perfusion'. Together they form a unique fingerprint.

Cite this